Cystic fibrosis disease severity correlates with plasma levels of desmosine and isodesmosine, biomarkers of elastin degradation Source: ERJ Open Res, 5 (2) 00250-2018; 10.1183/23120541.00250-2018 Year: 2019
Cigarette smoking acutely decreases the serum levels of the COPD biomarker sRAGE Source: International Congress 2018 – Novel findings in biomarkers of tobacco use, exposure, hazards and genetics Year: 2018
Total desmosines in plasma and urine correlate with lung function Source: Eur Respir J 2012; 39: 839-845 Year: 2012
Relationship between plasma amino acid levels and lung function decline in patients with COPD Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013
Plasma levels of TIPM-2 in patients with COPD Source: International Congress 2016 – Molecular targets in pulmonary disease Year: 2016
Serum BNP levels in COPD, asthma-COPD-overlap-syndrome, smokers and never-smokers Source: International Congress 2016 – Systemic biomarkers Year: 2016
Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD Source: Annual Congress 2013 –COPD treatment and others Year: 2013
Late Breaking Abstract - Increased serum levels of YKL-40 in male smoking chronic obstructive pulmonary disease patients associated with altered miRNA levels in alveolar macrophages Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020
Serum periostin but not airway POSTN expression is reduced in smokers with asthma Source: Annual Congress 2013 –Biomarkers in asthma and COPD Year: 2013
Different changes in plasma concentrations of cytokines and chemokines in patients with COPD associated with smoking and occupational exposures Source: International Congress 2016 – Human responses to exposure, including physiological and biomarker outcomes Year: 2016
Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD Source: Eur Respir J 2016; 47:1365-1373 Year: 2016
Blood eosinophils relate more closely to reduced lung function than serum ECP or plasma EDN in young asthmatics Source: International Congress 2016 – Systemic biomarkers Year: 2016
Elevation of surfactant protein A in plasma and sputum in cigarette smokers Source: Eur Respir J 2011; 38: 277-284 Year: 2011
Serum uric acid levels and uric acid/creatinine ratio in stable COPD patients: Are these parameters efficiently predict risky patients for exacerbation and/or severity of the disease? Source: International Congress 2016 – Biomarkers and phenotypes of COPD Year: 2016
The effects of endogenous and exogenous vitamin D on the rate of mature elastin degradation in COPD patients Source: International Congress 2016 – New signalling pathways in COPD Year: 2016
Relationship of circulating hyaluronic acid levels to disease control in asthma and asthmatic pregnancy Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013
Plasma markers of oxidative protein damage do not correlate with lung function or COPD in smokers Source: Eur Respir J 2006; 28: Suppl. 50, 144s Year: 2006
Associations between plasma sRAGE, esRAGE and AGEs in COPD Source: Annual Congress 2013 –Environmental and occupational respiratory diseases: new exposure assessment methods, experimental exposure in animal and humans and mechanisms Year: 2013
Increased levels of osteopontin in sputum supernatant in smoking asthma Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011
Plasma surfactant protein D (SP-D) and smoking status in patients with COPD Source: International Congress 2014 – COPD: points to ponder Year: 2014